The FDA is planning to make changes to the forms used by health professionals, drugmakers, and hospitals to report adverse events, and has put out a call for comments on these proposed revisions. The FDA would like feedback on whether the information is perceived as necessary, and ways to minimize the burden of the collection of information on respondents. (Regulatory Focus)